NeoGenomics Inc (NEO)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$11.74
Buy
$12.09
$0.08 (+0.68%)
Prices updated at 12 Dec 2025, 23:53 EST
| Prices minimum 15 mins delay
Prices in USD
NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 43.92 |
| 2023 | 41.34 |
| 2022 | 36.86 |
| 2021 | 38.62 |
| 2020 | 41.83 |
| 2019 | 48.15 |
| 2018 | 45.99 |
| 2017 | 42.44 |
| 2016 | 42.32 |
| 2015 | 43.84 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 2.13 |
| 2024 | 3.23 |
| 2023 | 3.52 |
| 2022 | 2.30 |
| 2021 | 8.60 |
| 2020 | 13.58 |
| 2019 | 7.82 |
| 2018 | 3.94 |
| 2017 | 2.79 |
| 2016 | 2.97 |
| 2015 | 4.91 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -4.74 |
| 2023 | -5.14 |
| 2022 | -7.99 |
| 2021 | -0.58 |
| 2020 | 0.49 |
| 2019 | 1.32 |
| 2018 | 1.43 |
| 2017 | -3.21 |
| 2016 | -8.95 |
| 2015 | -1.23 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.82 |
| 2023 | 1.79 |
| 2022 | 1.74 |
| 2021 | 1.69 |
| 2020 | 1.42 |
| 2019 | 1.40 |
| 2018 | 1.58 |
| 2017 | 2.00 |
| 2016 | 2.06 |
| 2015 | 1.68 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
